|
Organigram Holdings Inc (NASDAQ: OGI) |
|
Organigram Holdings Inc
OGI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Organigram Holdings Inc 's sales fell
by 0 % in IV. Quarter 2023 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.76 %
• More on OGI's Growth
|
|
Organigram Holdings Inc realized a net loss in trailing twelve months.
Organigram Holdings Inc realized cash reduction of $ 0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.05.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.
• More on OGI's Valuation
|
|
|
|
|
Organigram Holdings Inc realized net loss in trailing twelve months.
Organigram Holdings Inc realized cash outflow of $ 0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.05.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.4.
Organigram Holdings Inc Price to Book Ratio is at 0.56 lower than Industry Avg. of 88.19. and higher than S&P 500 Avg. of 0.02
• More on OGI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com